Allogeneic bone marrow transplantation for Philadelphia chromosome- positive chronic myelogenous leukemia in childhood

Journal of the Formosan Medical Association

Volumn 96, Issue 5, 1997, Pages 320-324

  Lin, Yu Tsan ^a   Lin, Dong Tsamn ^a   Jou, Shiann Tarng ^a   Lin, Kuo Sin ^a   Lin, Kai Hsin ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Accelerated phase; Blast crisis; Bone marrow transplantation; Children; Chronic myelogenous leukemia; Chronic phase; Philadelphia chromosome

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; FOLLOW UP; HLA SYSTEM; HUMAN; PHILADELPHIA 1 CHROMOSOME; PNEUMONIA; PROSPECTIVE STUDY; SURVIVAL RATE; TAIWAN;

BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; PROSPECTIVE STUDIES;

EID: 0031003636     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gamis AS, Haake R, McGlave P, et al: Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children. J Clin Oncol 1993;11:834-8.
2. Marks DI, Goldman JM: HLA-identical sibling bone marrow transplantation for chronic myeloid leukemia. In: Atkinson K, ed. Clinical Bone Marrow Transplantation. 1st ed. Cambridge: Cambridge University Press, 1994:197-203.
3. Champlin R, McGlave P: Allogeneic bone marrow transplantation for chronic myeloid leukemia. In: Forman SJ, Blume KG, Thomas ED, eds. Bone Marrow Transplantation. 1st ed. Boston: Blackwell Scientific Publications, 1994:595-606.
4. Biggs JC, Szer J, Crilley P, et al: Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BU-CYC2. Blood 1992;80:1352-7.
5. Brodsky I, Biggs JC, Szer J, et al: Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BU-CYC2): an update. Semin Oncol 1993;20:27-31.
6. Galimberti M, Polchi P, Lucarelli G, et al: Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase following preparation with busulfan and cyclophosphamide. Bone Marrow Transplant 1994;13:197-201.
7. Clift RA, Buckner CD, Thomas ED, et al: Marrow transplantation for patients in the accelerated phase of chronic myeloid leukemia. Blood 1994;84:4368-73.
8. Wagner JE, Zahurak M, Piantadosi S, et al: Bone marrow transplantation of chronic myelogenous leukemia in the chronic phase: evaluation of risks and benefits. J Clin Oncol 1992;10:779-89.
9. Heslop HE: Chronicmvelogenousleukemia. In: Behrman RE, Kliegman RM, Arvin AM, eds. Nelson Textbook of Pediatrics. 15th ed. Philadelphia: WB Saunders Company, 1996:1456-7.
10. McGlave PB, Beatty P, Ash R, et al: Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases. Blood 1990;75:1728-32.
11. Atkinson K: Unrelated donor bone marrow transplantation. In: Atkinson K, ed. Clinical Bone Marrow Transplantation. 1st ed Cambridge: Cambridge University Press, 1994:277-83.
12. Santos QW, Tutschka PJ, Brookmyer R, et al: Marrow transplantation for acute non-lymphocytic leukemia after treatment with busulfan and cyclophosphamide. New Engl J Med 1983;309:1347-53.
13. Storb R, Deeg HJ, Whitehead J, et al: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. New Engl J Med 1986;314:729-35.
14. Glucksberg H, Storb R, Fefer A, et al: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18:295-304.
15. Bacigalupo A, Gualandi F, Van Lint MT, et al: Multivariate analysis of risk factors for survival and relapse in chronic granulocytic leukemia following allogeneic marrow transplantation: impact of disease related variables (Sokal score). Bone Marrow Transplant 1993;12:443-8.
16. Goldman JM, Gale RP, Horowitz MM, et al: Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Ann Intern Med 1988;108: 806-14.
17. Goldman JM, Apperley JF, Jones L, et al: Bone marrow transplantation for patients with chronic myeloid leukemia. New Engl J Med 1986;314:202-7.
18. Thomas ED, Clift RA, Fefer A, et al: Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 1986;104:155-63.